Lygos Revenue and Competitors
Estimated Revenue & Valuation
- Lygos's estimated annual revenue is currently $13.6M per year.
- Lygos's estimated revenue per employee is $155,000
- Lygos's total funding is $50M.
Employee Data
- Lygos has 88 Employees.
- Lygos grew their employee count by 29% last year.
Lygos's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Sustainability Officer, Head Home Care | Reveal Email/Phone |
2 | CEO & Co-founder | Reveal Email/Phone |
3 | CTO | Reveal Email/Phone |
4 | VP, Process Scaleup & Manufacturing | Reveal Email/Phone |
5 | VP Legal Affairs | Chief Patent Counsel | Reveal Email/Phone |
6 | SVP Business Development | Reveal Email/Phone |
7 | Sr. Director, Brand Marketing | Reveal Email/Phone |
8 | Director Fermentation | Reveal Email/Phone |
9 | Senior Director Quality Assurance | Reveal Email/Phone |
10 | Director Business Development | Reveal Email/Phone |
Lygos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Lygos?
Lygos employs cutting edge synthetic biology techniques to generate microbial catalysts to convert agricultural feedstocks into fine and commodity chemicals. Our robust high throughput screening and strain construction facilitates the rapid optimization of pathways to convert cheap and renewable feedstock to high value chemicals.
keywords:Clean Energy, Advanced Materials, Synthetic Biology, Specialty Chemicals$50M
Total Funding
88
Number of Employees
$13.6M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lygos News
(Name of Issuer). Common Stock. (Title of Class of Securities). 33938T104. (CUSIP Number). Eric Steen. Chief Executive Officer. Lygos, Inc.
Under the terms of the merger agreement, Lygos issued $160 million worth of convertible notes with a 5.5% fixed annual interest rate and a...
Lygos has created a biological engineering platform focused on sustainable production of organic acid bio-monomers. Lygos' bio-based ingredients...
Partnership with U.S. Department of Energy and Agile BioFoundry to accelerate microbial engineering for cost-competitive production of new biochemicals June 03, 2019 08:00 AM Eastern Daylight Time BERKELEY, Calif.--(BUSINESS WIRE)--Lygos, Inc., a full-stack producer of specialty chemicals that d ...
Lygos, Inc., a Berkeley, CA-based biotechnology-based producer of specialty chemicals that deliver high-value performance without environmental toxicity, received a $5m investment from LG Technology Ventures, the investment arm of the South Korean conglomerate LG Group. The deal was part of the ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.6M | 88 | 4% | N/A |
#2 | $11.4M | 88 | -16% | $9M |
#3 | $3.5M | 89 | 41% | N/A |
#4 | $24M | 89 | -13% | N/A |
#5 | $7.5M | 89 | 14% | N/A |